ANXA1 and breast carcinoma: Western blots demonstrated knock-down of ANXA1 to inhibit the NF-κB pathway and the expression of mesenchymal markers (N-cadherin and SNAIL) as well as breast cancer cell migration and invasion (Fig. 6A, Fig. S9A-B).